Uncategorized
Mesoblast – The waiting game
The waiting game Nothing happens quickly in the world of biotech, and from an investor point of view this can be the toughest part. For shareholders in Melbourne based stem cell company, Mesoblast, the waiting game has been excruciating. As the world ground to a halt due to the Read more…